EBOS GROUP LIMITED (EBO)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

EBO - EBOS GROUP LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 2.25
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$34.69

30 Nov
2023

0.350

OPEN

$34.20

1.02%

HIGH

$34.97

146,634

LOW

$33.93

TARGET
$35.49 2.3% upside
Franking for last dividend paid out: 96%
OTHER COMPANIES IN THE SAME SECTOR
ACL . AHX . ALC . BMT . CAJ . DOC . HLA . HLS . M7T . MDR . MPL . MVF . NHF . PSQ . RHC . SHL . SLA .
FNARENA'S MARKET CONSENSUS FORECASTS
EBO: 1
Title FY22
Actual		 FY23
Actual		 FY24
Forecast		 FY25
Forecast
EPS (cps) xxx 132.9 154.8 xxx
DPS (cps) xxx 57.0 101.8 xxx
EPS Growth xxx 16.1% 16.5% xxx
DPS Growth xxx 16.3% 78.6% xxx
PE Ratio xxx N/A 22.7 xxx
Dividend Yield xxx N/A 2.9% xxx
Div Pay Ratio(%) xxx 42.9% 65.8% xxx

Dividend yield today if purchased 3 years ago: 2.21%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 1.51

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 07/09 - ex-div 46.77c (franking 96%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx132.9
DPS All xxxxxxxxxxxxxxx105.1
Sales/Revenue xxxxxxxxxxxxxxx12,237.4 M
Book Value Per Share xxxxxxxxxxxxxxx1,270.5
Net Operating Cash Flow xxxxxxxxxxxxxxx391.4 M
Net Profit Margin xxxxxxxxxxxxxxx2.07 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx10.78 %
Return on Invested Capital xxxxxxxxxxxxxxx7.07 %
Return on Assets xxxxxxxxxxxxxxx3.99 %
Return on Equity xxxxxxxxxxxxxxx10.78 %
Return on Total Capital xxxxxxxxxxxxxxx12.06 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx121.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx92 M
Long Term Debt xxxxxxxxxxxxxxx1,191 M
Total Debt xxxxxxxxxxxxxxx1,283 M
Goodwill - Gross xxxxxxxxxxxxxxx1,976 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx212 M
Price To Book Value xxxxxxxxxxxxxxx2.66

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx98.4 M
Capex % of Sales xxxxxxxxxxxxxxx0.80 %
Cost of Goods Sold xxxxxxxxxxxxxxx11,322 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx470 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx69 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

23/11/2023

4

Lighten

$28.50

-17.84%

After six days of trading halt, Ebos Group has abandoned its attempt to acquire vet business Greencross. Ord Minnett believes it is prudent for Ebos to be disciplined in its growth strategy and capital allocation.

A trading update for the first four months of FY24 highlighted resilient margins. The broker believes this is due to cost control and acquisitions in higher-margin medical technology offsetting cost pressures in labour and freight.

Believing the industry will remain challenging, Ord Minnett retains a Lighten rating. Fair value rises to $28.50 from $28.00.

FORECAST
Ord Minnett forecasts a full year FY24 dividend of 102.00 cents and EPS of 146.00 cents.
Ord Minnett forecasts a full year FY25 dividend of 102.50 cents and EPS of 146.60 cents.

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >

EBO STOCK CHART

FNArena News on EBO

1
Rudi’s View: Quality In Stocks; What Is It Good For?

Nov 22 2023 - Rudi's View
2
Rudi’s View: A Market Of Contradictions

Nov 01 2023 - Rudi's View
3
Sigma Healthcare Promises Higher Margins

Oct 03 2023 - Small Caps
4
Australian Broker Call *Extra* Edition – Aug 29, 2023

Aug 29 2023 - Daily Market Reports
5
Paw Patrol; Investing In Non-Discretionary Pets

Aug 28 2023 - Small Caps

Latest Healthcare services News

1
Treasure Chest: Ramsay Health Care

Oct 26 2023 - Treasure Chest
2
Timing Seems Right For Alcidion Group

Jun 21 2023 - Small Caps
3
No Enthusiasm To Combine ACL & Healius

Mar 21 2023 - Australia
4
Dr Boreham’s Crucible: Alcidion

Dec 13 2022 - Small Caps
5
No Straight Covid-Relief For Ramsay Health Care

Nov 15 2022 - Australia
6
Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022 - Small Caps
7
Negative Industry Trends Impact Australian Clinical Labs

Aug 12 2022 - Small Caps
8
Healius Offers Digital Carrot, Base Remains Soft

May 25 2022 - Australia
9
Ramsay Stakes Future on Mental Health

Dec 20 2021 - Australia
10
Ramsay Health Care: Finally A Break-Out

Nov 09 2021 - Technicals